All Industries

Top Life Sciences Companies

372 Life Sciences companies, sorted by total funding raised.

MISSION BIO INC

R&D company with 7 SBIR/STTR awards from Department of Health and Human Services, National Scienc...

SOUTH SAN FRANCISCO, United States1–10Biotech, Healthcare
Series C·$110.0M·Aug 2020
Kyverna TherapeuticsIPO

Kyverna is a cell therapy company engineering and developing a new class of curative living medic...

Emeryville, United States51–200Life Sciences, healthtech
Series B·$110.0M·Aug 2023
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
Series F·$109.0M·Jul 2010
SunBird Bio

Develops blood-based protein diagnostics for earlier, more accurate diagnosis and monitoring of A...

Cambridge, United States11–50Biotech, Diagnostics
Series B·$108.2M·Oct 2024
LivongoAcquired

Livongo provides digital health solutions to manage chronic conditions like diabetes, hypertensio...

Mountain View, United States501–1000Life Sciences, Digital Health
Series E·$105.0M·Apr 2018
Singular GenomicsAcquired

Develops high-throughput spatial multiomics sequencing platforms and services for research and cl...

La Jolla, United States201–500Genomics, Life Sciences
Venture Unknown·$104.0M·Feb 2021
MersanaClosed

Biopharmaceutical company that is creating the next generation of antibody drug conjugates using ...

Cambridge, United States51–200Antibody Drug Conjugates, Biotech
Series C·$103.0M·Jun 2016
Paratus Sciences

Biotech company using bat genomics and informatics to discover and develop novel therapeutics for...

New York, United States11–50Biotech, Life Sciences
Pre-seed·$102.5M·Jul 2025
Satellite Bio

Develops off-the-shelf liver cell therapies that deliver functional hepatocytes to restore liver ...

Cambridge, United States11–50Biotech, Life Sciences
Seed·$101.5M·Apr 2022
Gameto

Gameto is a biotechnology company whose mission is to redefine female reproductive health by deve...

New York, United States11–50Life Sciences
Series C·$100.0M·Aug 2025
Lightcast Discovery

Biotech company developing a droplet-based microfluidics platform for single-cell functional anal...

Cambridge, United Kingdom11–50Biotech, Healthcare
Series B·$97.1M·Aug 2023
Prolific Machines

Accelerating sustainable cell production

San Francisco, United States11–50Biotech, Healthcare
Series B·$97.0M·Jun 2024
Basking Biosciences

Basking Biosciences, a clinical-stage biopharmaceutical company, was founded to solve the biggest...

Columbus, United States1–10Life Sciences, Biotech
Extension Round·$94.9M·Oct 2025
Adonis

Adonis is an AI-powered revenue intelligence and automation platform built for healthcare, helpin...

New York, United States11–50Artificial Intelligence, Fintech
Series C·$93.9M·Mar 2026
Xilis

Develops MicroOrganoSphere ex vivo tumor models and AI analytics to guide precision oncology and ...

Durham, United States51–200Biotech, Diagnostics
Series A·$92.0M·Apr 2025
Nautilus BiotechnologyIPO

Accurate single-molecule quantification of proteins and proteoforms

Seattle, United States51–200Artificial Intelligence, Healthcare
Corporate Round·$90.7M·Jul 2021
Corvia

Develops the Corvia Atrial Shunt, a transcatheter implant for HFpEF and HFmrEF, used by hospitals...

Tewksbury, United States11–50Life Sciences, Hardware
Series D·$90.0M·Jun 2025
Tendo Systems

Healthcare technology platform delivering analytics, patient engagement, and a shoppable care mar...

Philadelphia, United States51–200Life Sciences, Data & Analytics
Growth Equity·$89.0M·Apr 2025
Conceivable

Reimagining the IVF lab to increase by 10X the number of families who can be helped to conceive.

New York, United States11–50Healthcare, Biotech
Series A·$88.0M·Sep 2025
Maxion Therapeutics

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Cambridge, United Kingdom11–50Life Sciences, Biotech
Series A·$88.0M·Mar 2025
Vizgen

Life sciences company developing spatial biology and multi-omics platforms to map gene and protei...

Cambridge, United States51–200Biotech, Life Sciences
Series C·$85.2M·Jun 2022
Tempest TherapeuticsIPO

A clinical-stage oncology company advancing small molecules that combine both targeted and immune...

Brisbane, United States11–50Biotech, Drug Discovery
Private Equity·$85.0M·Apr 2022
Averna Therapeutics

Averna Therapeutics is developing genomic medicines that insert therapeutic genes into safe harbo...

Watertown, United States11–50Life Sciences, Biotech
Series A·$82.0M·Jun 2024
Qualifyze

Founded in 2019, Qualifyze is a leading company in supply chain risk management in the Life Scien...

Frankfurt, Germany51–200Life Sciences, SaaS
Series B·$82.0M·Sep 2024
Mosanna Therapeutics

Improving the lives of patients with metabolic obstructive sleep apnea using a transformative app...

Redwood City, United States1–10Biotech, Sleep Apnea
Series A·$80.0M·Jun 2025